Billionaire Ken Griffin Just Loaded Up on Eli Lilly Stock. Should You?

Novo Nordisk A/S sigue siendo una compra a medida que aumenta Wegovy oral y se fortalece la cartera de GLP-1; un atractivo P/U para 2028 sugiere un potencial alcista. Haga clic para leer más sobre NVO.

Las acciones de Eli Lilly and Company (NYSE:LLY) suben un 1 % - Aquí

La farmacéutica Bristol-Myers Squibb Company (NYSE:BMY) está invirtiendo dinero real en su confianza en el sector manufacturero estadounidense. El 10 de agosto, la compañía dijo que gastará alrededor de 2.300 millones de dólares en una nueva planta en Houston, parte de una promesa de inversión mayor de 40.000 millones de dólares de Estados Unidos. El mismo día, los reguladores británicos autorizaron a Eli Lilly and Company (NYSE:LLY) […]

Amplitude Therapeutics y Chai Discovery firman colaboraciones de IA y ARN con Eli Lilly y Bristol Myers Squibb, Norstella

Heidi Ko se une a Eli Lilly como directora senior, médico de investigación clínica en cáncer de mama/cáncer de mama, atención del cáncer de mama, investigación del cáncer de mama, mama

Las acciones cotizaban recientemente a 1.280 dólares cada una, por lo que una división sería

Amplitude Therapeutics colabora con Eli Lilly para desarrollar vacunas de ARN transamplificadoras, mientras que Chai Discovery se asocia con Bristol Myers Squibb para implementar sus modelos de diseño y plegado molecular de IA en BMS.

Kelleher Financial Advisors lifted its holdings in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 187.1% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,498 shares of the company

Private Advisory Group LLC increased its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 13.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,932 shares of the company

M3 Wealth Management LLC purchased a new stake in shares of Eli Lilly and Company (NYSE:LLY - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 2,836 shares of the company

SMART Wealth LLC lowered its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 65.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 920 shares of the company

TFR Capital LLC. reduced its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 15.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,709 shares of the company

Stoneridge Investment Partners LLC acquired a new position in Eli Lilly and Company (NYSE:LLY - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 1,784 shares of the company

Russell Investments Group Ltd. trimmed its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 1.0% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 781,929 shares of the company